Webinar series: Clinical Evidence and Upcoming Studies

Clinical Evidence and Upcoming Studies

This video explores the clinical relevance of H3.1 in severe health conditions, such as COVID-19 and sepsis. We highlight clinical trials in France, the Netherlands, Germany and the U.S. that show a correlation between higher levels of H3.1 with increased patient severity, especially in intensive care.

Click here for the next video in our series: How Viruses Manipulate Basic Hemostasis to Their Advantage